Abstract: The invention relates to a polymer composition which absorbs infrared radiation (IR), containing a transparent thermoplastic plastic, an inorganic infrared absorber, also referred to as IR absorber hereinbelow, at least one inorganic nano-scale pigment, and the combination of at least two organic coloring agents of a specific structure, and to the preparation and use of the polymer compositions according to the invention and to products produced therefrom.

Abstract: Provided are a compound of Formula 1 and an organic light-emitting device including the compound. Descriptions of substituents of the Formula 1 are referred to in the detailed description.

Abstract: The present invention relates to new naphthalene carbodiimide (NTCDI) derivatives, and organic electronic device using the same and especially to an organic solar cell. The new NTCDI derivatives are used as acceptor, electron transport material, and doped electron transport materials.

Abstract: A compound for spacing nonlinear optical chromophores of the Formula I and the commercially acceptable salts, solvates and hydrates thereof, wherein R1, R2, R3, R4, W, X, Y, Z, Q1, Q2, Q4 and L have the definitions provided herein.

Abstract: A material for an organic electroluminescence device including at least one of compounds shown by the following formula (Ia), (Ib), (IIa), (IIb), (III), (IVa) or (IVb):

Abstract: The thiadiazole represented by formula (2) or (4), when used as a light-emitting material in a light-emitting element, allows the light-emitting element to emit near-infrared light: [In formulae (2) and (4), each R independently represents a hydrogen atom, an alkyl group, or a substituted or unsubstituted aryl group. There may be a ring formed by a carbon linkage between two adjacent R's.

Abstract: A material for an organic electroluminescence device including an indenofluorenedione derivative shown by the following formula (I): wherein X1 and X2, which may be the same or different, are any of specific divalent groups; R1 to R10, which may be the same or different, are a hydrogen atom, an alkyl group, an aryl group, a heterocycle, a halogen atom, a fluoroalkyl group, an alkoxy group, an aryloxy group or a cyano group; and R3 to R6 or R7 to R10 may be bonded to each other to form a ring.

Abstract: The present invention relates to organic colouring agents with a high colour stability to weathering for thermoplastics. The invention furthermore relates to a polymer composition containing at least one thermoplastic and at least one organic colouring agent, preferably a combination of at least two organic colouring agents, of a specific structure. The invention moreover relates to the use of the colouring agents according to the invention for colouring polymer compositions, in particular for transparent formulations such as are required for the production of panes for use in buildings, motor vehicles and track vehicles or aircraft.

Abstract: A material for an organic electroluminescence device including an indenofluorenedione derivative shown by the following formula (I): wherein X1 and X2, which may be the same or different, are any of specific divalent groups; R1 to R10, which may be the same or different, are a hydrogen atom, an alkyl group, an aryl group, a heterocycle, a halogen atom, a fluoroalkyl group, an alkoxy group, an aryloxy group or a cyano group; and R3 to R6 or R7 to R10 may be bonded to each other to form a ring.

Abstract: Briefly described, embodiments of this disclosure include charge-transport materials, methods of forming charge-transport materials, and methods of using the charge-transport materials.

Abstract: (+)-Avrainvillamide, a naturally occurring alkaloid with antiproliferative activity, is shown to bind to the oncoprotein nucleophosmin. Nucleophosmin is known to regulate the tumor suppressor protein p53 and is overexpressed in many different human tumors. The invention provides methods of modulating nucleophosmin and p53 using (+)-avrainvillamide and analogues thereof. These compounds may provide leads for the development of novel anti-cancer therapies that target nucleophosmin.

Abstract: The syntheses of the natural products, avrainvillamide and stephacidin B, are provided. The ?,?-unsaturated nitrone functionality of avrainvillamide and its 3-alkylidene-3H-indole 1-oxide core is shown to covalently and reversibly bond to heteroatom-based nucleophiles. This capability may allow these molecules to bind active site nucleophiles and may provide the basis for designing potent and selective enzyme inhibitors. Both avrainvillamide and its dimer stephacidin B have been reported to exhibit antiproliferative activity, and avrainvillamide has been reported to exhibit antimicrobial activity against multi-drug resistant bacteria. Avrainvillamide has been found to target cytoskeleton-linking membrane protein (CLIMP-63) thereby preventing cells from undergoing mitosis. The invention provides syntheses of these natural products as well as analogs of these natural products and their functional cores.

Abstract: Briefly described, embodiments of this disclosure include charge-transport materials, methods of forming charge-transport materials, and methods of using the charge-transport materials.

Abstract: Compounds of the saframycin-ecteinascidin series with cytotoxic properties having the following general formula, their uses and synthesis, are disclosed: wherein R1 and R4 is H, a C1 to C4 alkyl group, or an acyl group; wherein R2 is an ether, ester, amide, or a phthalimide group; wherein R3 is ═O, OH, an ether group, an acyl group such as OC(O)Me, OC(O)Bn and OC(O)Et, or a sulfide group; wherein R5 is H, halogen, OH, an ether group, an acyl group, or an amide group; wherein R6 is ═O, OH, OCH3, CN, or an acyloxy group; wherein R7, is ═O, OH, halogen, an ether group, or an acyl group; wherein R8 and R9 are independently H, CH3, OCH3, OC2H5, CF3, halogen such as Br and F, or R8 and R9 are joined together as a methylenedioxy group, or other five or six membered ring; wherein R10 and R11 are independently CH3, OCH3, OC2H5, SCH3, or SC2H5; wherein R12 is H, a C1 to C4 alkyl group, or an acyl group; and wherein the chiral center marked * has the R or the S configuration.

Abstract: The present invention are marefortines and paraherquamides where the 7-member oxygenated ring has been modified to produce 25-methylene compounds (VII) and 24,25-epoxy compounds (VIII) all of which are useful as antiparasitic agents against endo and ecto parasites, particularly helminths and arthropods.

Abstract: The present invention includes various substituted and paraherquamides, exemplified by the 14-hydroxy-2-deoxoparaherquamide B of formula (XXV) which are useful as antiparasitic agents.

Abstract: The present invention includes various substituted marcfortines of the type exemplfied by the compounds of formula ##STR1## and paraherquamides which are useful as antiparasitic agents.

Abstract: This invention relates to antibiotic 31F508.alpha..sub.1, 31F508.alpha..sub.2, 31F508.beta..sub.1 and 31F508.beta..sub.2, derived from the microorganism Streptomyces viridodiastaticus subsp. "littus" which are useful as an anti-bacterial agent.

Abstract: This invention relates to antibiotic 31F508.alpha..sub.1 of the formula ##STR1## 31F508.alpha..sub.2, 31F508.beta..sub.1 and 31F508.beta..sub.2, derived from the microorganism Streptomyces viridodiastaticus subsp. "littus" which are useful as anti-bacterial agents.

Abstract: 7,16-Dichlorodianthraquinone-N,N'-dihydroazine (I) ##STR1## is prepared by condensing 1-amino-3-chloroanthraquinone (II) in the presence of an alkaline condensing aid, of an oxidizing agent and of a urea derivative (III) ##STR2## (R: identical or different alkyl groups having 1 to 4 carbon atoms, which may be joined together to form a 5- or 6-membered ring that contains the urea group).

Abstract: A process for preparing dianthraquinone-N,N'-dihydroazine (I) ##STR1## and its chlorination products (Ia) ##STR2## where n is 1 or 2, by condensation of 1-aminoanthraquinone (II) in the presence of an alkaline condensing aid, an oxidizing agent and a cyclic urea derivative at from 80.degree. to 150.degree. C. and subsequent purification and/or chlorination comprises using N,N'-dimethylpropyleneurea as the urea derivative.

Abstract: Pyrazole derivatives of a variety of polycyclic pigments, particularly quinacridone pigments, corresponding to the general formula ##STR1## wherein Q is the primary pigment structure; and the use of such derivatives as additives to pigment systems to provide a broad range of performance benefits to the resulting pigment compositions.

Abstract: Diketopiperazine compounds designated N-methylepiamauromine, epiamauromine and cycloechinulin have been isolated from the sclerotia of the fungi Aspergillus ochraceus. The compounds are effective for controlling Coleopteran and Lepidopteran insects.

Abstract: Pigment preparation essentially comprisinga) at least one pigment from the class of azo, anthrapyrimidine, anthanthrone, quinacridone, perinone, diketopyrrolopyrrole, dioxazine, flavanthrone, indanthrone, isoindolinone, isoviolanthrone, perylene, phthalocyanine, pyranthrone or thioindigo pigments or a mixture of pigments belonging to various classes, andb) at least one dispersant of the formula (I) ##STR1## in which P, independently of the pigments mentioned in a), is a radical of an anthanthrone azo, quinacridone, perinone, diketopyrrolopyrrole, dioxazine, indanthrone, perylene, phthalocyanine or thioindigo pigment,R.sup.1 and R.sup.2, independently of one another, are hydrogen, halogen, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.

Abstract: Delta-opioid receptor antagonists are disclosed of the formula: ##STR1## wherein R.sup.1 is (C.sub.1 -C.sub.5)alkyl, C.sub.3 -C.sub.6 (cycloalkyl)alkyl, C.sub.5 -C.sub.7 (cycloalkenyl)alkyl, aryl, aralkyl, trans-(C.sub.4 -C.sub.5)alkenyl, allyl or furan-2-ylalkyl, R.sup.2 is H, OH or O.sub.2 CR, wherein R is (C.sub.1 -C.sub.5)alkyl; R.sup.3 is H, (C.sub.1 -C.sub.5)alkyl or RCO; X is O, S or NY, wherein Y is H or (C.sub.1 -C.sub.5)alkyl; M is N or CH; and R.sup.4 and R.sup.5 are individually H, F, Cl, Br, NO.sub.2, NH.sub.2, (C.sub.1 -C.sub.5)alkyl or (C.sub.1 -C.sub.5)alkoxy or R.sup.4 and R.sup.5 together are benzo; and the pharmaceutically acceptable salts thereof.

Abstract: A process for producing dianthraquinone-N,N'-dihydrazine or its chlorination product, which comprises condensing 1-aminoanthraquinone at an elevated temperature in the presence of 1,3-dimethyl-2-imidazolidinone using an oxidizing agent and an alkaline condensing agent, and subjecting the resulting condensation product to a treatment known per se.